Skip to main content

Table 3 Adjusted effects of A− and T-status on MMP- and TIMP-levels in CU controls and patients

From: Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease

Dependent variable/independent variable

MMP-2

MMP-3

MMP-10

TIMP-1

TIMP-2

TIMP-3

TIMP-4

A+ status

− 0.13

− 0.18*

− 0.07

− 0.14

− 0.11

− 0.19

− 0.25**

T+ status

0.24**

0.39**

0.37**

0.16**

0.16**

0.17**

0.43**

Age

0.31**

0.11*

0.13**

0.36**

0.22**

0.11*

0.05

Male sex

0.32**

0.18**

0.20**

0.26**

0.34**

0.27**

0.04

APOE ε4 carrier

0.05

0.06

0.08

0.13*

0.05

0.10

0.14*

MCI (vs. CU)

0.07

0.09

0.16*

0.01

0.26**

0.07

0.16*

Dementia (vs. CU)

0.00

0.19

0.33**

0.10

0.35**

0.16

0.12

Adjusted R2

0.28

0.20

0.29

0.23

0.24

0.11

0.19

  1. Standardised β-coefficients are presented. *P < 0.05, ** P < 0.01. A+: biomarkers positive for Aβ pathology, APOE: apolipoprotein E, CU cognitively unimpaired, MCI mild cognitive impairment, MMP matrix metalloproteinase, T+: biomarkers positive for tau pathology, TIMP tissue inhibitor of matrix metalloproteinase